HCW Biologics Inc.

0.28
-0.00 (-0.32%)
At close: Apr 02, 2025, 3:59 PM
0.29
1.30%
After-hours: Apr 02, 2025, 05:51 PM EDT

HCW Biologics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio -0.58 -1.77 -4.66 -6.72 -40 -32.02
PEG Ratio -0.06 -0.02 -0.27 -0.06 2.00 n/a
PS Ratio 6.74 15.55 10.20 n/a 56.40 n/a
PB Ratio -2.56 3.28 1.83 1.62 16.06 25.69
P/FCF Ratio -1.19 -1.54 -3.32 -7.53 -21.78 -28.11
P/OCF Ratio -1.22 -1.96 -6.6 -7.56 -22.17 -34.18
OCF/S Ratio -5.54 -7.92 -1.55 n/a -2.54 n/a
Debt / Equity Ratio -0.93 0.47 0.17 n/a 0.04 n/a
Quick Ratio 0.19 0.73 11.05 16.49 11.60 7.53
Current Ratio 0.19 0.73 11.52 17.44 12.14 7.53
Asset Turnover 0.08 0.10 0.14 n/a 0.27 n/a
Interest Coverage 46.71 -90.86 -119.05 n/a n/a n/a
Return on Equity 4.43 -1.86 -0.39 -0.24 -0.4 -0.8
Return on Assets -0.99 -0.88 -0.31 -0.23 -0.38 -0.72
Return on Invested Capital -4.26 -1.3 -0.34 -0.25 -0.39 -0.81
Dividend Yield n/a n/a n/a 0.03 n/a n/a
Payout Ratio n/a n/a n/a -0.23 n/a n/a
Gross Profit Margin 0.37 0.20 0.38 n/a 1.00 n/a
Net Profit Margin -11.7 -8.8 -2.19 n/a -1.41 n/a
Pretax Profit Margin -11.7 -8.8 -2.22 n/a -1.42 n/a
Operating Profit Margin -11.49 -9.05 -2.24 n/a -1.42 n/a
FCF Margin -564.48 -1.01K -307.36 n/a -258.99 n/a
EBITDA Margin -11.49 -8.3 -2.11 n/a -1.28 n/a